Dr Stephen Silberstein Compares the Effects of Erenumab on Chronic, Episodic Migraine
Because patients with chronic migraine experience more monthly migraine days (MMD) than those with episodic migraine, chronic migraineurs will experience a greater reduction of MMD with erenumab, said Stephen Silberstein, MD, professor of neurology at Thomas Jefferson University and director of the Headache Center at Jefferson Health.
Watch video Dr Stephen Silberstein Compares the Effects of Erenumab on Chronic, Episodic Migraine online, duration hours minute second in high quality that is uploaded to the channel AJMCtv 07 October 2020. Share the link to the video on social media so that your subscribers and friends will also watch this video. This video clip has been viewed 155 times and liked it 1 visitors.
